Lindholm J
Department of Endocrinology, Aalborg University Hospital, 9000, Aalborg, Denmark,
Pituitary. 2014 Aug;17(4):374-80. doi: 10.1007/s11102-013-0509-x.
The dexamethasone (DXM) test has been widely used for diagnosing Cushing's disease (CD). The purpose of this paper is to review its diagnostic merit based on calculation of data extracted from earlier publications. Studies presenting individual values for patients with CD and normal subjects were identified through PubMed searches and references in pertinent studies. Calculation of the retrieved data demonstrated huge variation in the relative suppressibility, negative suppression being common. Furthermore, in almost each study retrieved, the pre and post DXM values were closely correlated. Finally, the generally accepted view that DXM causes less suppression in Cushing's disease than in euadrenal controls appears unfounded. A central issue in the definition of so-called "pseudo-Cushing's states" is failure to suppress cortisol secretion with DXM. From analysis of the literature it appears quite possible that this does not reflect a specific endocrine deficit, but a physiological "stress" reaction. The above issues question the diagnostic value of the test, in particular in clinically and biochemically borderline cases.
地塞米松(DXM)试验已被广泛用于库欣病(CD)的诊断。本文旨在通过对早期出版物中提取的数据进行计算,回顾其诊断价值。通过PubMed检索和相关研究中的参考文献,确定了呈现库欣病患者和正常受试者个体值的研究。对检索到的数据进行计算表明,相对抑制率存在巨大差异,阴性抑制很常见。此外,在几乎每一项检索到的研究中,地塞米松给药前后的值密切相关。最后,普遍认为地塞米松在库欣病中引起的抑制作用比在正常肾上腺对照中少这一观点似乎没有根据。所谓“假性库欣状态”定义中的一个核心问题是地塞米松不能抑制皮质醇分泌。从文献分析来看,这很可能并不反映特定的内分泌缺陷,而是一种生理“应激”反应。上述问题质疑了该试验的诊断价值,尤其是在临床和生化临界病例中。